Mont., Lilly Reach $9.5M Deal In Zyprexa MDL

Law360, New York (February 23, 2010, 6:16 PM EST) -- Montana has become the latest state to reach a deal with Eli Lilly & Co. over its promotion and marketing of antipsychotic drug Zyprexa, with the drugmaker agreeing to pay $9.5 million into a state settlement fund.

Montana's attorney general lodged a motion to approve the consent judgment Tuesday in the U.S. District Court for the Eastern District of New York, where a multidistrict litigation over Lilly's marketing of the drug has been pending for years.

According to the motion, the settlement fund will resolve contested...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.